The global next-generation oncology devices and solutions market report highlights that the market was valued at $3,268.2 million in 2021 and is expected to reach $5,971.3 million by the end of 2031. The market is expected to grow at a CAGR of 6.41% during the forecast period from 2022 to 2031.
The global operating room management solutions market was valued at $2,023.5 million in 2021 and is expected to reach $3,699.1 million by 2031. The market is expected to grow at a CAGR of 6.29% during the forecast period from 2022 to 2031.
As per BIS Research analysis, the population sequencing market is projected to reach $64,047.6 million by 2030 from $21,730.4 million in 2020, at a CAGR of 11.41% during the forecast period, 2020-2030.
The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032.
Energy Management System Market: Increasing Demand for Energy Conservation an...AmanpreetSingh409
The energy management system has garnered adoption in commercial sectors across various business organizations. The use of energy management systems has helped the residential consumers to analyze a set of data collected from sensors planted at the site.
Read Report Preview: https://bisresearch.com/industry-report/energy-management-system-market.html
Energy Management System Market is expected to increase at a CAGR of 23.37 percent from 2020 to 2025, from $10.55 billion in 2020 to $30.15 billion in 2025. The increasing demand for energy conservation and environmental safety is likely to fuel the growth of the energy management system market.
Visit: https://bisresearch.com/industry-report/energy-management-system-market.html
Acellular Therapy Market - Strategies and Applications.pdfBIS Research Inc.
Acellular Therapy Market market to grow at a significant CAGR. Acellular Therapy Market market report by BIS Research provides deep market insight, industry analysis, trends.
This document provides an overview and analysis of the global radioligand therapy market from 2021-2031. It discusses key market drivers such as the rising prevalence of cancer and strategic initiatives by market players. The document also analyzes the market by indication, product, biomarker, and region. It includes profiles of major companies in the market such as Johnson & Johnson Services, Inc., Pfizer Inc., Amneal Pharmaceuticals LLC, Novartis International AG, POINT Biopharma Global Inc., and Fusion Pharma. Pipeline products and ongoing clinical trials are also reviewed.
The global mobility-as-a-service market analysis by BIS Research projects the market to grow at a significant CAGR of 25.10% during the forecast period from 2020 to 2025.
The global operating room management solutions market was valued at $2,023.5 million in 2021 and is expected to reach $3,699.1 million by 2031. The market is expected to grow at a CAGR of 6.29% during the forecast period from 2022 to 2031.
As per BIS Research analysis, the population sequencing market is projected to reach $64,047.6 million by 2030 from $21,730.4 million in 2020, at a CAGR of 11.41% during the forecast period, 2020-2030.
The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032.
Energy Management System Market: Increasing Demand for Energy Conservation an...AmanpreetSingh409
The energy management system has garnered adoption in commercial sectors across various business organizations. The use of energy management systems has helped the residential consumers to analyze a set of data collected from sensors planted at the site.
Read Report Preview: https://bisresearch.com/industry-report/energy-management-system-market.html
Energy Management System Market is expected to increase at a CAGR of 23.37 percent from 2020 to 2025, from $10.55 billion in 2020 to $30.15 billion in 2025. The increasing demand for energy conservation and environmental safety is likely to fuel the growth of the energy management system market.
Visit: https://bisresearch.com/industry-report/energy-management-system-market.html
Acellular Therapy Market - Strategies and Applications.pdfBIS Research Inc.
Acellular Therapy Market market to grow at a significant CAGR. Acellular Therapy Market market report by BIS Research provides deep market insight, industry analysis, trends.
This document provides an overview and analysis of the global radioligand therapy market from 2021-2031. It discusses key market drivers such as the rising prevalence of cancer and strategic initiatives by market players. The document also analyzes the market by indication, product, biomarker, and region. It includes profiles of major companies in the market such as Johnson & Johnson Services, Inc., Pfizer Inc., Amneal Pharmaceuticals LLC, Novartis International AG, POINT Biopharma Global Inc., and Fusion Pharma. Pipeline products and ongoing clinical trials are also reviewed.
The global mobility-as-a-service market analysis by BIS Research projects the market to grow at a significant CAGR of 25.10% during the forecast period from 2020 to 2025.
Automotive Smart Tire Market - A Global Market and Regional AnalysisBIS Research Inc.
This document provides an overview and analysis of the global automotive smart tire market. It begins with executive summaries of the key topics and then covers the market segments of application, products, and regions. For each segment, it discusses the market size and demand analysis, key players, business drivers and challenges, and regional analyses for North America, South America, Europe, and key countries within those regions. The purpose is to give an in-depth examination of the current state and future outlook of the emerging automotive smart tire industry.
Ambulatory Surgical Center Operating Room Integration Systems Market BIS Research Inc.
The global ambulatory surgical center operating room integration systems market is projected to reach $5,668.2 million by 2032 from $2,077.5 million in 2021, at a CAGR of 9.88% during the forecast period 2022-2032.
The Non-invasive prenatal testing (NIPT) market is projected to reach $10,818.4 Million by 2030 from $2,182.3 Million in 2020, at a CAGR of 15.83% during the forecast period, 2020-2030.
Global Minimally Invasive Surgical Systems Market.pdfBIS Research Inc.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031
Healthcare experts have found the epigenetics market to be one of the highest booming markets, and the global market is predicted to grow at a CAGR of 17.11% during the forecast period 2021-2031.
The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.
Bio-LNG Market is anticipated to reach $3,607.2 million by 2032.pdfMohit BISResearch
Bio-LNG Market is anticipated to reach $3,607.2 million by 2032. the high cost of bio-LNG as compared to LNG is anticipated to hinder market growth in the future.
Read Report Overview: https://bisresearch.com/industry-report/bio-lng-market.html
AI-Enabled Imaging Solutions Market - A Global Market Report by BIS ResearchBIS Research Inc.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032. you can get more info to visit this link..
https://bisresearch.com/industry-report/global-ai-enabled-medical-imaging-solutions-market.html
Electric Vehicle Fast-Charging System Market - Analysis & ForecastBIS Research Inc.
This document provides an overview of the global electric vehicle fast-charging system market with a focus on DC fast charging systems for public and private use. It analyzes the market by connector type, charging power output, applications, and regions. The report segments the market by connector type (CHADeMO, CCS, Tesla Supercharger, GB/T), charging power (<100 kW, 100-200 kW, >200 kW), applications (public, private), and regions (North America, South America, Europe). It also discusses industry trends, emerging technologies, policies, business models and provides a market forecast for 2020-2025.
Electric Vehicle Fast-Charging System Market - A Global and Regional AnalysisBIS Research Inc.
This document provides an overview of the global electric vehicle fast-charging system market with a focus on DC fast charging systems for public and private use. It analyzes the market by connector type, charging power output, applications, and regions. The report segments the market by connector type (CHADeMO, CCS, Tesla Supercharger, GB/T), charging power (<100 kW, 100-200 kW, >200 kW), applications (public, private), and regions (North America, South America, Europe). It also discusses industry trends, emerging technologies, policies, business models, and competitive landscape. Detailed market data by volume is presented for products and applications segmented by region and country.
Agriculture Drones and Robots Market Growth Opportunity, Trends, Demand Analy...BIS Research Inc.
Agriculture drones and robots offer multiple benefits over conventional farming equipment, which is another factor driving the demand for these products in the agriculture industry. The adoption of agriculture drones and robots in commercial farms offers huge cost-saving opportunities.
Request for the Sample of the Report at: https://bisresearch.com/requestsample?id=1425&type=download
This document provides an overview and analysis of the global wearable patches market. It covers the market outlook, trends, dynamics, segmentation based on application, usage type, end user, and region. The regional sections analyze the market in North America, Europe, Asia-Pacific, and major countries within those regions. It also discusses the impact of COVID-19 on wearable patch adoption and market growth. The report includes market forecasts from 2022-2031 for the global market and its segments under various growth scenarios.
Global Neurostimulation Devices Market - Global Industry AnalysisBIS Research Inc.
Neurostimulation devices consider the implantable and non-implantable neurostimulation devices which act on the spinal cord and brain to deliver the electrical stimulation to a targeted area.
Pharmaceutical Aseptic Transfer Market Analysis and Forecast, 2022-2031BIS Research Inc.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
Our healthcare experts have found COVID-19 Diagnostic Testing industry to be one of the most rapidly evolving and dynamic markets and the global market for COVID-19 diagnostic testing is predicted to grow at a CQGR of 23.50% over the forecast period of 3Q2020-4Q2021.
Flow Cytometry in Oncology and Immunology Market Analysis and Forecast, 2022-...BIS Research Inc.
The global flow cytometry in oncology and immunology market is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
Supersonic and Hypersonic Aircraft Market is expected to reach $5,400.4 million by 2032. Supersonic and hypersonic aircraft manufacturing industry comprises aircraft manufacturers, subsystem manufacturers, and end users.
Read Report Overview: https://bisresearch.com/industry-report/supersonic-hypersonic-aircraft-market.html
The global dental radiography market is expected to reach $3,914.8 million by the end of 2031. The market is expected to grow at a CAGR of 5.17% during the forecast period 2022-2031.
Vehicle diagnostic analytics market value to reach $4,425.6 million by 2031. Growth in the vehicle diagnostics Analytics Industry to be driven by the growing demand for automotive diagnostic analytics in fleet management.
Read Report Overview: https://bisresearch.com/industry-report/vehicle-diagnostic-analytics-market.html
Request A Sample: https://bisresearch.com/requestsample?id=1401&type=download
Webinar Presentation Syndromic Testing – A New Take on Diagnosing Infectious ...BIS Research Inc.
The document summarizes a webinar on syndromic testing for diagnosing infectious diseases. The webinar featured several speakers who discussed topics like: how syndromic testing can provide faster results and reduce antibiotic use compared to traditional testing; applications of metagenomics next-generation sequencing (mNGS) in clinical diagnostics and its benefits; key trends in the syndromic testing market like high growth rates and the dominance of respiratory disease testing currently. The global syndromic testing market is expected to grow from $1.28 billion in 2022 to $3.25 billion in 2033, driven by factors like rising infectious disease incidence and the need for early diagnosis.
The global sustainable steel market is projected to reach $795.8 billion by 2031 from $327.3 billion in 2021, growing at a CAGR of 8.97% during the forecast period 2022-2031. The growth in the global sustainable steel market is expected to be driven by stringent government regulations, carbon neutrality targets, energy and cost efficiency owing to the use of recycled steel, and a significant increase in steel demand with the scarcity of raw materials and energy.
More Related Content
Similar to Global Next Generation Oncology Devices and Solutions Market.pdf
Automotive Smart Tire Market - A Global Market and Regional AnalysisBIS Research Inc.
This document provides an overview and analysis of the global automotive smart tire market. It begins with executive summaries of the key topics and then covers the market segments of application, products, and regions. For each segment, it discusses the market size and demand analysis, key players, business drivers and challenges, and regional analyses for North America, South America, Europe, and key countries within those regions. The purpose is to give an in-depth examination of the current state and future outlook of the emerging automotive smart tire industry.
Ambulatory Surgical Center Operating Room Integration Systems Market BIS Research Inc.
The global ambulatory surgical center operating room integration systems market is projected to reach $5,668.2 million by 2032 from $2,077.5 million in 2021, at a CAGR of 9.88% during the forecast period 2022-2032.
The Non-invasive prenatal testing (NIPT) market is projected to reach $10,818.4 Million by 2030 from $2,182.3 Million in 2020, at a CAGR of 15.83% during the forecast period, 2020-2030.
Global Minimally Invasive Surgical Systems Market.pdfBIS Research Inc.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031
Healthcare experts have found the epigenetics market to be one of the highest booming markets, and the global market is predicted to grow at a CAGR of 17.11% during the forecast period 2021-2031.
The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.
Bio-LNG Market is anticipated to reach $3,607.2 million by 2032.pdfMohit BISResearch
Bio-LNG Market is anticipated to reach $3,607.2 million by 2032. the high cost of bio-LNG as compared to LNG is anticipated to hinder market growth in the future.
Read Report Overview: https://bisresearch.com/industry-report/bio-lng-market.html
AI-Enabled Imaging Solutions Market - A Global Market Report by BIS ResearchBIS Research Inc.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032. you can get more info to visit this link..
https://bisresearch.com/industry-report/global-ai-enabled-medical-imaging-solutions-market.html
Electric Vehicle Fast-Charging System Market - Analysis & ForecastBIS Research Inc.
This document provides an overview of the global electric vehicle fast-charging system market with a focus on DC fast charging systems for public and private use. It analyzes the market by connector type, charging power output, applications, and regions. The report segments the market by connector type (CHADeMO, CCS, Tesla Supercharger, GB/T), charging power (<100 kW, 100-200 kW, >200 kW), applications (public, private), and regions (North America, South America, Europe). It also discusses industry trends, emerging technologies, policies, business models and provides a market forecast for 2020-2025.
Electric Vehicle Fast-Charging System Market - A Global and Regional AnalysisBIS Research Inc.
This document provides an overview of the global electric vehicle fast-charging system market with a focus on DC fast charging systems for public and private use. It analyzes the market by connector type, charging power output, applications, and regions. The report segments the market by connector type (CHADeMO, CCS, Tesla Supercharger, GB/T), charging power (<100 kW, 100-200 kW, >200 kW), applications (public, private), and regions (North America, South America, Europe). It also discusses industry trends, emerging technologies, policies, business models, and competitive landscape. Detailed market data by volume is presented for products and applications segmented by region and country.
Agriculture Drones and Robots Market Growth Opportunity, Trends, Demand Analy...BIS Research Inc.
Agriculture drones and robots offer multiple benefits over conventional farming equipment, which is another factor driving the demand for these products in the agriculture industry. The adoption of agriculture drones and robots in commercial farms offers huge cost-saving opportunities.
Request for the Sample of the Report at: https://bisresearch.com/requestsample?id=1425&type=download
This document provides an overview and analysis of the global wearable patches market. It covers the market outlook, trends, dynamics, segmentation based on application, usage type, end user, and region. The regional sections analyze the market in North America, Europe, Asia-Pacific, and major countries within those regions. It also discusses the impact of COVID-19 on wearable patch adoption and market growth. The report includes market forecasts from 2022-2031 for the global market and its segments under various growth scenarios.
Global Neurostimulation Devices Market - Global Industry AnalysisBIS Research Inc.
Neurostimulation devices consider the implantable and non-implantable neurostimulation devices which act on the spinal cord and brain to deliver the electrical stimulation to a targeted area.
Pharmaceutical Aseptic Transfer Market Analysis and Forecast, 2022-2031BIS Research Inc.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
Our healthcare experts have found COVID-19 Diagnostic Testing industry to be one of the most rapidly evolving and dynamic markets and the global market for COVID-19 diagnostic testing is predicted to grow at a CQGR of 23.50% over the forecast period of 3Q2020-4Q2021.
Flow Cytometry in Oncology and Immunology Market Analysis and Forecast, 2022-...BIS Research Inc.
The global flow cytometry in oncology and immunology market is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
Supersonic and Hypersonic Aircraft Market is expected to reach $5,400.4 million by 2032. Supersonic and hypersonic aircraft manufacturing industry comprises aircraft manufacturers, subsystem manufacturers, and end users.
Read Report Overview: https://bisresearch.com/industry-report/supersonic-hypersonic-aircraft-market.html
The global dental radiography market is expected to reach $3,914.8 million by the end of 2031. The market is expected to grow at a CAGR of 5.17% during the forecast period 2022-2031.
Vehicle diagnostic analytics market value to reach $4,425.6 million by 2031. Growth in the vehicle diagnostics Analytics Industry to be driven by the growing demand for automotive diagnostic analytics in fleet management.
Read Report Overview: https://bisresearch.com/industry-report/vehicle-diagnostic-analytics-market.html
Request A Sample: https://bisresearch.com/requestsample?id=1401&type=download
Similar to Global Next Generation Oncology Devices and Solutions Market.pdf (20)
Webinar Presentation Syndromic Testing – A New Take on Diagnosing Infectious ...BIS Research Inc.
The document summarizes a webinar on syndromic testing for diagnosing infectious diseases. The webinar featured several speakers who discussed topics like: how syndromic testing can provide faster results and reduce antibiotic use compared to traditional testing; applications of metagenomics next-generation sequencing (mNGS) in clinical diagnostics and its benefits; key trends in the syndromic testing market like high growth rates and the dominance of respiratory disease testing currently. The global syndromic testing market is expected to grow from $1.28 billion in 2022 to $3.25 billion in 2033, driven by factors like rising infectious disease incidence and the need for early diagnosis.
The global sustainable steel market is projected to reach $795.8 billion by 2031 from $327.3 billion in 2021, growing at a CAGR of 8.97% during the forecast period 2022-2031. The growth in the global sustainable steel market is expected to be driven by stringent government regulations, carbon neutrality targets, energy and cost efficiency owing to the use of recycled steel, and a significant increase in steel demand with the scarcity of raw materials and energy.
Cybersecurity in Automotive Connected Vehicles and Growing Security Vulnerabi...BIS Research Inc.
• Agenda:
o To evaluate various security vulnerabilities in connected vehicles.
o To analyze the initiatives taken and regulations implemented to address security vulnerabilities.
o To analyze the various types of cybersecurity solutions being developed or offered for the security of connected vehicles.
o To evaluate the major players in the ecosystem.
Report Preview is available at: https://bisresearch.com/industry-report/global-automotive-cybersecurity-market.html
BIS Research conducted a webinar on Carbon Neutral Data Center PracticesBIS Research Inc.
Agenda:
To evaluate various emerging trends in Data center industry.
To analyze the initiatives taken and regulations implemented to increase sustainable practices.
To analyze the various types of technologies currently deployed.
To evaluate the major players in the ecosystem.
Speaker Profiles:
Name: JD Enright, Sr.
Designation: Chief Operating Officer
Company: TMGcore Inc.
Experienced and dedicated business professional with 29 years working with DOD, Multinational Private and Public sector organizations. Primary focus on developing and executing Strategic Step-Up Growth initiatives in Emerging Markets, and Technologies. Specialized leadership in developing improved business operations to include Financial and Operational efficiencies. Implementation of next generation HPC Platforms, Global Blockchain Development Strategies, Biotechnology, Viral Cell and Gene Therapies and Market Intelligence Assimilation for public applications.
Webinar by BIS Research on Precision Oncology BiomarkersBIS Research Inc.
Precision oncology biomarkers are essential tools for tailoring cancer treatment to individual patients, as they provide insights into tumor biology and guide the selection of targeted therapies.
BIS conducted a deep intelligence webinar on the state-of-the-art technologies and emerging strategies used through the precision oncology biomarkers.
Direct-to-Customer Wellness | A Webinar on the Growing Need for Personalized ...BIS Research Inc.
Direct-to-consumer (DTC) wellness testing industry witnessed a strong emphasis on consumer health and wellness, instigating industry stakeholders to discover new revenue streams.
As a leading market intelligence firm, BIS Research strives to stay on top of the latest emerging trends in the healthcare sector, among several other industry verticals. In the bid to do the same, BIS is conducting a deep intelligence webinar on the increasing focus of DTC wellness programs in the healthcare sector.
Read Related Reports Overview at:
https://bisresearch.com/industry-report/global-direct-to-consumer-genetic-testing-market.html
https://bisresearch.com/industry-report/us-dtc-wellness-testing-market.html
Emerging Battery Chemistries | Reimagining EVs Beyond Conventional Li-Ion Bat...BIS Research Inc.
The efficiency of the battery system in any electric vehicle (EV) determines its cost and vehicle performance. Challenges, such as range anxiety and charging time, have been a hindrance to increasing EV sales.
As a leading market intelligence firm, BIS Research strives to stay on top of the latest emerging technologies in the mobility sector, among several other industry verticals.
In the bid to do the same, BIS is conducting a deep intelligence webinar on the current paradigm shift happening for battery technologies in electric vehicles.
Here are all the details:
Webinar Topic: Emerging Battery Chemistries | Reimagining EVs Beyond Conventional Li-Ion Batteries
Webinar on AI in Medical Diagnosis with Emerging TechnologiesBIS Research Inc.
Artificial Intelligence (AI) is a rapidly growing field that has the potential to revolutionize the way medical diagnosis is performed. AI systems use advanced algorithms to analyze large amounts of data, such as medical images, patient histories, and lab results, to identify patterns and make predictions about patient outcomes.
In medical diagnosis, AI can be used in a variety of ways, including medical imaging, disease diagnosis, personalized treatment planning, and early disease detection. By leveraging the power of AI, healthcare providers can make faster and more accurate diagnoses, resulting in better patient outcomes.
Agenda:
The main agenda of this webinar is to understand and explore the following:
• Policy implications related to AI and digital transformation in healthcare.
• Initiatives taken and regulations implemented to address cybersecurity concerns.
• Major factors driving and hindering the growth of AI in medical devices diagnosis.
• Major players in the ecosystem
The global demand for achieving the net zero emission target by 2050 has pushed governments all over to adapt and adopt advanced carbon removal technologies to go carbon negative.
It is, indeed, an important topic of discussion, because a carbon free environment is the need of the hour to save our planet. And, therefore, BIS Research is glad to announce its upcoming webinar on this particular subject.
Agenda:
The main agenda of this webinar is to understand and explore the following:
• Primary sources of carbon emissions and associated environmental issues
• Carbon dioxide removal – key technology and adoption scenario
• Carbon dioxide removal (CDR): trends and key market developments
• Carbon dioxide removal as a credible solution
• Conclusion and future outlook
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy DevelopmentBIS Research Inc.
Agenda of the Webinar:
Cell and Gene Therapy Biomanufacturing Market: Trends and Key Developments
Awaited Technologies in the Cell and Gene Therapy Development
Regulatory Scenario – GMP/cGMP Guidelines
Biomanufacturing 4.0 - Adoption Scenario
Conclusion and Future Outlook
Sub-Orbital Testing Services Market Future Growth and Business Opportunities ...BIS Research Inc.
Sub-orbital platforms are increasing access to the near space-like environment for end users such as government agencies, research institutions, and commercial players.
The competitive landscape of the sub-orbital testing services market consists of several organic and inorganic strategies followed by the key players to increase their market share.
The space industry is continuously innovating and developing advanced technologies with the objective of enhancing space capabilities. The industry is gearing up to develop vehicles that entail a major feature, i.e., reusability.
Request for the sample of the report at: https://bisresearch.com/requestsample?id=1442&type=download
TOC - Global Military Robotic and Autonomous Systems (RAS) Market.pdfBIS Research Inc.
The robotic and autonomous system (RAS) is a multidisciplinary scientific and technological domain for implementing complex systems with cognitive capabilities.
RAS in military is being rigorously introduced and used in combat training. This has boosted the capabilities of armed units and subunits. The advent of artificial intelligence (AI) and its integration with military RAS has the potential to change future warfare.
Growing demand to increase warfighter lethality and remove soldiers from dangerous situations is propelling the global military RAS market.
Request for the sample of the report at: https://bisresearch.com/requestsample?id=1442&type=download
UAV Propulsion System Market Analysis, Statistics, Regional, and Forecast to ...BIS Research Inc.
UAV propulsion system manufacturers have also been inclined to counter the environment and other government regulations by developing sustainable propulsion, i.e., steps toward fossil-free aviation fuels and ion propulsion are a few of such significant innovations.
UAVs can be powered by a variety of different types of engines, including piston engines, turbine engines, Wankel engines, and electric and solar-powered engines.
The global UAV propulsion system market has witnessed a high growth rate in the last five to six years owing to its widespread applications across various industries, which were further bolstered by the COVID-19 pandemic.
Publication of BIS Research on UAV Propulsion System market has some great insights for UAV Propulsion Systems. Get free sample here: https://bisresearch.com/requestsample?id=1443&type=download
Fleet Management Market Trends, Key Players, Industry Analysis and Forecast 2...BIS Research Inc.
A fleet management system, which includes hardware, software and service, has the ability to make decisions for fleet managers and fleet businesses easily.
The ongoing research and development activities in this market are experiencing product launches of fleet management system for fleet owners, fleet managers, or businesses that utilize fleet management on a daily basis.
BIS Research has a new publication on Fleet Management, view free sample here : https://bisresearch.com/requestsample?id=1444&type=download
Agenda:
The main agenda of this webinar is to understand and explore the following:
• LoRaWAN adoption in agricultural applications as well as understanding the trends and key market developments.
• The significance of LoRaWAN in the field of IoT
• A comparative analysis between LoRaWAN and other IoT networks in terms of technology and capabilities.
• The impact of LoRaWAN on the operations of the agriculture industry and common use cases.
• The impact of the implementation of LoRaWAN technology on stakeholders in the agriculture ecosystem.
• The potential challenges that LoRaWAN might face in the future.
• The competitiveness of the market for LoRaWAN technology.
Augmented Reality in Agriculture Analysis and Statistics from 2022-2027BIS Research Inc.
AR depicts superimposing visual, audio, or other sensory data onto the physical world to improve one's experience. It is one of the most popular technological trends in today’s times. AR images can be displayed on a variety of devices, including eyeglasses and goggles, headsets, and heads-up displays such as helmet visors. As more smartphones, tablets, and other handheld devices that support AR are becoming available globally, the most popular way to use AR is on these devices in a variety of apps and games.
Although AR is used to visually communicate information, it is the integration of AR with other technologies that make it possible to adapt to precision farming and visual-based operations. Hence, farmers can utilize AR in combination with other technologies such as artificial intelligence (AI), big data, and the Internet of Things (IoT) to manage the rising food demand.
Get Augmented Reality in Agriculture report overview at: https://bisresearch.com/industry-report/ar-agriculture-market.html
Smart Harvest Market Generated Opportunities, Future Scope 2022-2027BIS Research Inc.
The growth in the global smart harvest market is expected to be driven by increasing smart farming practices among farmers, labor shortage, and growing government support for promoting the use of smart tech in the agriculture industry. Supported by government policies and technological developments, farmers and growers across the globe are expected to increase the implementation of smart harvest technologies. Moreover, the smart harvest market is witnessing several upcoming trends and opportunities, further propelling growth in the industry.
Get the PDF document on the technical aspects of Smart Harvest Market at: https://bisresearch.com/requestsample?id=1386&type=download
Precision Pest Management Market Leading Players, Development and Demand Fore...BIS Research Inc.
While farmers are losing crops due to pests, they have pressure to increase food production to feed the growing world population.
Precision pest management (PPM) is very important to avoid destruction caused by pests and to increase productivity. PPM helps to detect pests early with the help of crop monitoring so they can be controlled early to avoid further losses. The availability of advanced technologies and equipment has made agriculture automation more prevalent in developed countries.
To know more about the in-depth insights on precision pest management market, get PDF document: https://bisresearch.com/requestsample?id=1404&type=download
Next-Generation Automotive Lighting Industry to See Significant Growth During...BIS Research Inc.
Since the inception of automotive vehicles amongst the masses, automotive lighting has witnessed significant growth owing to the growing safety apprehensions revolving around vehicles.
The rapid technical progress in the automotive lighting field shows that basic light sources based on incandescent and gas-release bulbs have shifted to modern-day technologies such as light-emitting diodes (LEDs), laser technology, and organic light-emitting diodes (OLEDs).
Get the Sample of the Report containing the information on various technical aspects at: https://bisresearch.com/requestsample?id=1435&type=download
Automotive Cybersecurity Market Current Trends And Restraints Forecast 2031BIS Research Inc.
Automotive Cybersecurity Market - A Global and Regional Analysis Focus on Product, Application, and Country Analysis - Analysis and Forecast, 2022-2031.
The increase in the connectivity of a vehicle’s center control module has increased the vehicle’s vulnerability to cyberattacks with less safety and security.
Request for the sample report at: https://bisresearch.com/requestsample?id=1436&type=download
Emotional and Behavioural Problems in Children - Counselling and Family Thera...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Get Covid Testing at Fit to Fly PCR TestNX Healthcare
A Fit-to-Fly PCR Test is a crucial service for travelers needing to meet the entry requirements of various countries or airlines. This test involves a polymerase chain reaction (PCR) test for COVID-19, which is considered the gold standard for detecting active infections. At our travel clinic in Leeds, we offer fast and reliable Fit to Fly PCR testing, providing you with an official certificate verifying your negative COVID-19 status. Our process is designed for convenience and accuracy, with quick turnaround times to ensure you receive your results and certificate in time for your departure. Trust our professional and experienced medical team to help you travel safely and compliantly, giving you peace of mind for your journey.www.nxhealthcare.co.uk
Mental Health and well-being Presentation. Exploring innovative approaches and strategies for enhancing mental well-being. Discover cutting-edge research, effective strategies, and practical methods for fostering mental well-being.
Sectional dentures for microstomia patients.pptxSatvikaPrasad
Microstomia, characterized by an abnormally small oral aperture, presents significant challenges in prosthodontic treatment, including limited access for examination, difficulties in impression making, and challenges with prosthesis insertion and removal. To manage these issues, customized impression techniques using sectional trays and elastomeric materials are employed. Prostheses may be designed in segments or with flexible materials to facilitate handling. Minimally invasive procedures and the use of digital technologies can enhance patient comfort. Education and training for patients on prosthesis care and maintenance are crucial for compliance. Regular follow-up and a multidisciplinary approach, involving collaboration with other specialists, ensure comprehensive care and improved quality of life for microstomia patients.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...DrDevTaneja1
Digital India will need a big trained army of Health Informatics educated & trained manpower in India.
Presently, generalist IT manpower does most of the work in the healthcare industry in India. Academic Health Informatics education is not readily available at school & health university level or IT education institutions in India.
We look into the evolution of health informatics and its applications in the healthcare industry.
HIMMS TIGER resources are available to assist Health Informatics education.
Indian Health universities, IT Education institutions, and the healthcare industry must proactively collaborate to start health informatics courses on a big scale. An advocacy push from various stakeholders is also needed for this goal.
Health informatics has huge employment potential and provides a big business opportunity for the healthcare industry. A big pool of trained health informatics manpower can lead to product & service innovations on a global scale in India.
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
Global Next Generation Oncology Devices and Solutions Market.pdf
1. 1
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
sres
Attribution: https://pixabay.com/photos/tire-rim-car-mechanic-114259/
Focus on Clinical Application, End User,
Type, and Region
Analysis and Forecast: 2022-2031
June 2022
Next-Generation
Oncology Devices
and Solutions
Market- A Global
and Regional
Analysis
Table of Content
3. 3
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
Table of Content
Executive Summary..........................................................................23
Scope of the Study ...........................................................................27
Research Methodology.....................................................................29
1. Markets .....................................................................................35
1.1 Global Market Outlook ....................................................................................36
1.1.1 Product Definition .......................................................................................36
1.1.2 Inclusion and Exclusion Criteria................................................................36
1.1.3 Key Findings................................................................................................36
1.1.4 Assumptions and Limitations ....................................................................37
1.1.5 Global Market Scenario...............................................................................38
1.1.5.1 Realistic Growth Scenario ................................................................................. 38
1.1.5.2 Optimistic Growth Scenario ............................................................................... 39
1.1.5.3 Pessimistic/Conservative Growth Scenario ....................................................... 40
1.2 Industry Outlook..............................................................................................40
1.2.1 Key Trends...................................................................................................40
1.2.1.1 Emerging Use of Wearables.............................................................................. 40
1.2.1.2 Growing Demand for Point-of-Care Testing (POCT) in Oncology ..................... 41
1.2.1.3 Growing Popularity of Smartphone-Based Diagnostics..................................... 41
1.2.1.4 Growing Demand for Minimally Invasive Methods of Cancer Diagnosis ........... 41
1.2.1.5 Rising Number of Partnerships and Regulatory Milestones .............................. 42
1.2.2 Opportunity Assessment............................................................................42
1.2.2.1 Short-Term Potential.......................................................................................... 42
1.2.2.2 Long-Term Potential .......................................................................................... 43
1.2.3 Patent Analysis............................................................................................44
1.2.3.1 Awaited Technological Developments............................................................... 44
1.2.3.2 Patent Filing Trend (by Country)........................................................................ 44
4. 4
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
1.2.3.3 Patent Filing Trend (by Year)............................................................................. 45
1.2.4 Product Benchmarking...............................................................................45
1.2.5 End-User Perceptions.................................................................................48
1.2.6 Case Studies................................................................................................48
1.2.6.1 Stereotactic Body Radiation Therapy (SBRT) using TrueBeam for
Inoperable Early-Stage Non-Small Cell Lung Cancer (NSCLC)........................ 48
1.2.6.2 Breast Cancer Treatment Using Halcyon .......................................................... 49
1.3 Impact of COVID-19 on the Next-Generation Oncology Devices and
Solutions Market..............................................................................................49
1.3.1 Impact on Adoption of Oncology Solutions..............................................49
1.3.2 Impact on Market Size.................................................................................50
1.3.2.1 Pre-COVID-19 Phase ........................................................................................ 50
1.3.2.2 During COVID-19 Phase ................................................................................... 50
1.3.2.3 Post-COVID-19 Phase....................................................................................... 50
1.3.3 Market Entry Barriers and Opportunities ..................................................51
1.4 Business Dynamics.........................................................................................51
1.4.1 Impact Analysis ...........................................................................................51
1.4.2 Business Drivers .........................................................................................52
1.4.2.1 Increasing Prevalence of Oncology and a Growing Geriatric Population .......... 52
1.4.2.2 Increase in Demand for Software Solutions in Oncology .................................. 53
1.4.2.3 Emerging Technologies in Oncology Testing and Treatment............................ 53
1.4.2.4 Rising Preference for Minimally Invasive Techniques of Diagnosis and
Treatment .......................................................................................................... 54
1.4.3 Business Restraints....................................................................................54
1.4.3.1 Side Effects and Risks Associated with Cancer Treatment............................... 54
1.4.3.2 Dearth of Well-Trained and Skilled Professionals in Oncology ......................... 55
1.4.4 Business Opportunities..............................................................................55
1.4.4.1 Increasing Demand for Home-Based Cancer Testing....................................... 55
1.4.4.2 Growing Demand for Targeted Therapy ............................................................ 56
5. 5
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
2. Global Next-Generation Oncology Devices and Solutions
Market, (by Clinical Application) ................................................57
2.1 Opportunity Assessment ................................................................................58
2.2 Growth-Share Matrix .......................................................................................59
2.3 Lung Cancer.....................................................................................................59
2.4 Prostate Cancer ...............................................................................................60
2.5 Breast Cancer ..................................................................................................61
2.6 Others ...............................................................................................................62
3. Global Next-Generation Oncology Devices and Solutions
Market (by End User) .................................................................64
3.1 Opportunity Assessment ................................................................................65
3.2 Growth-Share Matrix .......................................................................................66
3.3 Hospitals...........................................................................................................66
3.4 Diagnostic Imaging Centers ...........................................................................67
3.5 Others (Ambulatory Surgical Centers, Cancer Care Centers, and
Government Institutions) ................................................................................68
4. Global Next-Generation Oncology Devices and Solutions
Market (by Type)........................................................................70
4.1 Opportunity Assessment ................................................................................71
4.2 Growth-Share Matrix .......................................................................................72
4.3 Devices .............................................................................................................73
4.3.1 By Technology.............................................................................................73
4.3.1.1 High-Intensity Focused Ultrasound.................................................................... 73
4.3.1.2 Advanced Forms of Radiation Therapy ............................................................. 75
4.3.1.3 Others................................................................................................................ 77
4.3.2 By Application .............................................................................................78
4.3.2.1 Diagnosis........................................................................................................... 78
6. 6
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
4.3.2.2 Treatment and Monitoring.................................................................................. 79
4.4 Software ...........................................................................................................82
4.4.1 By Application .............................................................................................82
4.4.1.1 Diagnosis........................................................................................................... 82
4.4.1.2 Treatment and Monitoring.................................................................................. 83
5. Region .......................................................................................86
5.1 North America Next-Generation Oncology Devices and Solutions
Market ...............................................................................................................88
5.1.1 Key Findings and Opportunity Assessment .............................................88
5.1.2 Regulatory Framework................................................................................89
5.1.3 Key Players in North America ....................................................................90
5.1.4 Market Dynamics.........................................................................................91
5.1.4.1 Impact Analysis.................................................................................................. 92
5.1.5 Sizing and Forecast Analysis.....................................................................93
5.1.5.1 North America Next-Generation Oncology Devices and Solutions Market
(by Clinical Application) ..................................................................................... 93
5.1.5.2 North America Next-Generation Oncology Devices and Solutions Market
(by End User)..................................................................................................... 94
5.1.5.3 North America Next-Generation Oncology Devices and Solutions Market
(by Type)............................................................................................................ 94
5.1.5.3.1 North America Next-Generation Oncology Devices and Solutions Market,
Devices (by Technology)......................................................................................... 95
5.1.5.3.2 North America Next-Generation Oncology Devices and Solutions Market,
Device (by Application) ........................................................................................... 95
5.1.5.3.3 North America Next-Generation Oncology Devices and Solutions Market,
Software (by Application) ........................................................................................ 96
5.1.5.4 North America Next-Generation Oncology Devices and Solutions Market
(by Country)....................................................................................................... 97
5.1.5.4.1 U.S. .......................................................................................................................... 97
5.1.5.4.1.1 Market Dynamics.............................................................................................. 97
7. 7
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
5.1.5.4.1.2 Sizing and Forecast Analysis ........................................................................... 98
5.1.5.4.1.3 U.S. Next-Generation Oncology Devices and Solutions Market (by
Clinical Application)................................................................................................. 99
5.1.5.4.1.4 U.S. Next-Generation Oncology Devices and Solutions Market (by End
User)........................................................................................................................ 99
5.1.5.4.2 Canada................................................................................................................... 100
5.1.5.4.2.1 Market Dynamics............................................................................................ 100
5.1.5.4.2.2 Sizing and Forecast Analysis ......................................................................... 101
5.1.5.4.2.3 Canada Next-Generation Oncology Devices and Solutions Market (by
Clinical Application)............................................................................................... 101
5.1.5.4.2.4 Canada Next-Generation Oncology Devices and Solutions Market (by
End User) .............................................................................................................. 102
5.2 Europe Next-Generation Oncology Devices and Solutions Market ..........103
5.2.1 Key Findings and Opportunity Assessment ...........................................103
5.2.2 Regulatory Framework..............................................................................103
5.2.3 Key Players in Europe...............................................................................104
5.2.4 Market Dynamics.......................................................................................106
5.2.4.1 Impact Analysis................................................................................................ 107
5.2.5 Sizing and Forecast Analysis...................................................................107
5.2.5.1 Europe Next-Generation Oncology Devices and Solutions Market (by
Clinical Application) ......................................................................................... 108
5.2.5.2 Europe Next-Generation Oncology Devices and Solutions Market (by End
User)................................................................................................................ 108
5.2.5.3 Europe Next-Generation Oncology Devices and Solutions Market (by
Type)................................................................................................................ 109
5.2.5.3.1 Europe Next-Generation Oncology Devices and Solutions Market, Devices
(by Technology)..................................................................................................... 109
5.2.5.3.2 Europe Next-Generation Oncology Devices and Solutions Market, Device (by
Application)............................................................................................................ 110
5.2.5.3.3 Europe Next-Generation Oncology Devices and Solutions Market, Software
(by Application)...................................................................................................... 111
8. 8
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
5.2.5.4 Europe Next-Generation Oncology Devices and Solutions Market (by
Country)........................................................................................................... 111
5.2.5.4.1 Germany ................................................................................................................ 112
5.2.5.4.1.1 Market Dynamics............................................................................................ 112
5.2.5.4.1.2 Sizing and Forecast Analysis ......................................................................... 112
5.2.5.4.1.2.1 Germany Next-Generation Oncology Devices and Solutions Market (by
Clinical Application) ....................................................................................................113
5.2.5.4.1.2.2 Germany Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................113
5.2.5.4.2 U.K. ........................................................................................................................ 114
5.2.5.4.2.1 Market Dynamics............................................................................................ 114
5.2.5.4.2.2 Sizing and Forecast Analysis ......................................................................... 114
5.2.5.4.2.2.1 U.K. Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................115
5.2.5.4.2.2.2 U.K. Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................115
5.2.5.4.3 France.................................................................................................................... 116
5.2.5.4.3.1 Market Dynamics............................................................................................ 116
5.2.5.4.3.2 Sizing and Forecast Analysis ......................................................................... 117
5.2.5.4.3.2.1 France Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................117
5.2.5.4.3.2.2 France Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................118
5.2.5.4.4 Italy......................................................................................................................... 118
5.2.5.4.4.1 Market Dynamics............................................................................................ 118
5.2.5.4.4.2 Sizing and Forecast Analysis ......................................................................... 119
5.2.5.4.4.2.1 Italy Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................119
5.2.5.4.4.2.2 Italy Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................120
5.2.5.4.5 Spain...................................................................................................................... 120
5.2.5.4.5.1 Market Dynamics............................................................................................ 120
5.2.5.4.5.2 Sizing and Forecast Analysis ......................................................................... 121
5.2.5.4.5.2.1 Spain Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................121
9. 9
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
5.2.5.4.5.2.2 Spain Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................122
5.2.5.4.6 Rest-of-Europe....................................................................................................... 122
5.2.5.4.6.1 Market Dynamics............................................................................................ 122
5.2.5.4.6.2 Sizing and Forecast Analysis ......................................................................... 123
5.2.5.4.6.2.1 Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by
Clinical Application) ....................................................................................................123
5.2.5.4.6.2.2 Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by
End User) ...................................................................................................................124
5.3 Asia-Pacific Next-Generation Oncology Devices and Solutions
Market .............................................................................................................125
5.3.1 Key Findings and Opportunity Assessment ...........................................125
5.3.2 Regulatory Framework..............................................................................125
5.3.3 Key Players in Asia-Pacific.......................................................................126
5.3.4 Market Dynamics.......................................................................................127
5.3.4.1 Impact Analysis................................................................................................ 129
5.3.5 Sizing and Forecast Analysis...................................................................130
5.3.5.1 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by
Clinical Application) ......................................................................................... 130
5.3.5.2 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by
End User)......................................................................................................... 131
5.3.5.3 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by
Type)................................................................................................................ 131
5.3.5.3.1 Asia-Pacific Next-Generation Oncology Devices and Solutions Market,
Devices (by Technology)....................................................................................... 132
5.3.5.3.2 Asia-Pacific Next-Generation Oncology Devices and Solutions Market,
Device (by Application) ......................................................................................... 133
5.3.5.3.3 Asia-Pacific Next-Generation Oncology Devices and Solutions Market,
Software (by Application) ...................................................................................... 133
5.3.5.4 Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by
Country)........................................................................................................... 134
5.3.5.4.1 Japan ..................................................................................................................... 134
10. 10
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
5.3.5.4.1.1 Market Dynamics............................................................................................ 134
5.3.5.4.1.2 Sizing and Forecast Analysis ......................................................................... 135
5.3.5.4.1.2.1 Japan Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................136
5.3.5.4.1.2.2 Japan Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................136
5.3.5.4.2 China...................................................................................................................... 137
5.3.5.4.2.1 Market Dynamics............................................................................................ 137
5.3.5.4.2.2 Sizing and Forecast Analysis ......................................................................... 137
5.3.5.4.2.2.1 China Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................138
5.3.5.4.2.2.2 China Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................138
5.3.5.4.3 Australia ................................................................................................................. 139
5.3.5.4.3.1 Market Dynamics............................................................................................ 139
5.3.5.4.3.2 Sizing and Forecast Analysis ......................................................................... 139
5.3.5.4.3.2.1 Australia Next-Generation Oncology Devices and Solutions Market (by
Clinical Application) ....................................................................................................140
5.3.5.4.3.2.2 Australia Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................140
5.3.5.4.4 India ....................................................................................................................... 141
5.3.5.4.4.1 Market Dynamics............................................................................................ 141
5.3.5.4.4.2 Sizing and Forecast Analysis ......................................................................... 141
5.3.5.4.4.2.1 India Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................142
5.3.5.4.4.2.2 India Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................142
5.3.5.4.5 South Korea ........................................................................................................... 143
5.3.5.4.5.1 Market Dynamics............................................................................................ 143
5.3.5.4.5.2 Sizing and Forecast Analysis ......................................................................... 143
5.3.5.4.5.2.1 South Korea Next-Generation Oncology Devices and Solutions Market (by
Clinical Application) ....................................................................................................144
5.3.5.4.5.2.2 South Korea Next-Generation Oncology Devices and Solutions Market (by
End User) ...................................................................................................................144
5.3.5.4.6 Rest-of-Asia-Pacific ............................................................................................... 145
11. 11
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
5.3.5.4.6.1 Market Dynamics............................................................................................ 145
5.3.5.4.6.2 Sizing and Forecast Analysis ......................................................................... 145
5.3.5.4.6.2.1 Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions
Market (by Clinical Application) ..................................................................................146
5.3.5.4.6.2.2 Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions
Market (by End User)..................................................................................................147
5.4 Rest-of-the-World Next-Generation Oncology Devices and Solutions
Market .............................................................................................................148
5.4.1 Key Findings and Opportunity Assessment ...........................................148
5.4.2 Regulatory Framework..............................................................................148
5.4.3 Key Players in Rest-of-the-World.............................................................149
5.4.4 Market Dynamics.......................................................................................150
5.4.4.1 Impact Analysis................................................................................................ 151
5.4.5 Sizing and Forecast Analysis...................................................................151
5.4.5.1 Rest-of-the-World Next-Generation Oncology Devices and Solutions
Market (by Clinical Application) ....................................................................... 152
5.4.5.2 Rest-of-the-World Next-Generation Oncology Devices and Solutions
Market (by End User)....................................................................................... 152
5.4.5.3 Rest-of-the-World Next-Generation Oncology Devices and Solutions
Market (by Type).............................................................................................. 153
5.4.5.3.1 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market,
Devices (by Technology)....................................................................................... 153
5.4.5.3.2 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market,
Device (by Application) ......................................................................................... 154
5.4.5.3.3 Rest-of-the-World Next-Generation Oncology Devices and Solutions Market,
Software (by Application) ...................................................................................... 155
5.4.5.4 Rest-of-the-World Next-Generation Oncology Devices and Solutions
Market (by Country)......................................................................................... 155
5.4.5.4.1 Kingdom of Saudi Arabia (K.S.A.).......................................................................... 156
5.4.5.4.1.1 Market Dynamics............................................................................................ 156
5.4.5.4.1.2 Sizing and Forecast Analysis ......................................................................... 157
12. 12
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
5.4.5.4.1.2.1 K.S.A. Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................157
5.4.5.4.1.2.2 K.S.A. Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................158
5.4.5.4.2 Brazil ...................................................................................................................... 158
5.4.5.4.2.1 Market Dynamics............................................................................................ 158
5.4.5.4.2.2 Sizing and Forecast Analysis ......................................................................... 159
5.4.5.4.2.2.1 Brazil Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................159
5.4.5.4.2.2.2 Brazil Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................160
5.4.5.4.3 U.A.E...................................................................................................................... 160
5.4.5.4.3.1 Market Dynamics............................................................................................ 160
5.4.5.4.3.2 Sizing and Forecast Analysis ......................................................................... 161
5.4.5.4.3.2.1 U.A.E. Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................161
5.4.5.4.3.2.2 U.A.E. Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................162
5.4.5.4.4 Mexico.................................................................................................................... 162
5.4.5.4.4.1 Market Dynamics............................................................................................ 162
5.4.5.4.4.2 Sizing and Forecast Analysis ......................................................................... 163
5.4.5.4.4.2.1 Mexico Next-Generation Oncology Devices and Solutions Market (by Clinical
Application).................................................................................................................163
5.4.5.4.4.2.2 Mexico Next-Generation Oncology Devices and Solutions Market (by End
User)...........................................................................................................................164
5.4.5.4.5 Rest-of-Rest-of-the-World...................................................................................... 164
5.4.5.4.5.1 Market Dynamics............................................................................................ 164
5.4.5.4.5.2 Sizing and Forecast Analysis ......................................................................... 165
5.4.5.4.5.2.1 Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions
Market (by Clinical Application) ..................................................................................165
5.4.5.4.5.2.2 Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions
Market (by End User)..................................................................................................166
6. Markets - Competitive Benchmarking......................................167
6.1 Competitive Landscape ................................................................................168
13. 13
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
6.1.1 Key Strategies and Developments...........................................................168
6.1.1.1 Regulatory and Legal Activities ....................................................................... 169
6.1.1.2 Partnerships, Alliances, and Business Expansions ......................................... 170
6.1.1.3 New Offerings.................................................................................................. 171
6.1.1.4 Mergers and Acquisitions ................................................................................ 171
6.1.1.5 Funding Activities............................................................................................. 172
6.2 Market Share Analysis ..................................................................................173
14. 14
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
List of Figures
Figure 1: Global Next-Generation Oncology Devices and Solutions Market, Impact Analysis
Figure 2: Global Next-Generation Oncology Devices and Solutions Market (by Region), $Million, 2021 and
2031
Figure 3: Global Next-Generation Oncology Devices and Solutions Market Segmentation
Figure 4: Global Next-Generation Oncology Devices and Solutions Market Research Methodology
Figure 5: Primary Research
Figure 6: Secondary Research
Figure 7: Data Triangulation
Figure 8: Global Next-Generation Oncology Devices and Solutions Market Research Process
Figure 9: Assumptions and Limitations
Figure 10: Global Next-Generation Oncology Devices and Solutions Market, Potential Forecast Scenarios
Figure 11: Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential
(Realistic Scenario), $Million, 2020-2031
Figure 12: Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential
(Optimistic Scenario), $Million, 2020-2031
Figure 13: Global Next-Generation Oncology Devices and Solutions Market Size and Growth Potential
(Pessimistic/Conservative Scenario), $Million, 2020-2031
Figure 14: Global Next-Generation Oncology Devices and Solutions Market Key Trends, Short-Term
Potential
Figure 15: Global Next-Generation Oncology Devices and Solutions Market Key Trends, Long-Term
Potential
Figure 16: Global Next-Generation Oncology Devices and Solutions Market, Patent Analysis (by Country),
January 2018-April 2022
Figure 17: Global Next-Generation Oncology Devices and Solutions Market, Patent Analysis (by Year),
January 2018–April 2022
Figure 18: Key Players’ Product Offerings (by Type)
Figure 19: Global Next-Generation Oncology Devices and Solutions Market, Pre-COVID-19 Phase, $Million,
2020-2031
Figure 20: Global Next-Generation Oncology Devices and Solutions Market, Impact Analysis
Figure 21: Global Number of New Cases for All Cancers, 2020-2040
Figure 22: Global Next-Generation Oncology Devices and Solutions Market (by Clinical Application)
Figure 23: Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by
Clinical Application), $Million, 2021-2031
15. 15
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
Figure 24: Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by
Clinical Application), 2021-2031
Figure 25: Global Next-Generation Oncology Devices and Solutions Market (Lung Cancer), $Million, 2020-
2031
Figure 26: Global Next-Generation Oncology Devices and Solutions Market (Prostate Cancer), $Million,
2020-2031
Figure 27: Global Next-Generation Oncology Devices and Solutions Market (Breast Cancer), $Million, 2020-
2031
Figure 28: Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031
Figure 29: Global Next-Generation Oncology Devices and Solutions Market (by End User)
Figure 30: Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by
End User), $Million, 2021-2031
Figure 31: Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by End
User), 2021-2031
Figure 32: Global Next-Generation Oncology Devices and Solutions Market (Hospitals), $Million, 2020-2031
Figure 33: Global Next-Generation Oncology Devices and Solutions Market (Diagnostic Imaging Centers),
$Million, 2020-2031
Figure 34: Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031
Figure 35: Global Next-Generation Oncology Devices and Solutions Market (by Type)
Figure 36: Global Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by
Type), $Million, 2021-2031
Figure 37: Global Next-Generation Oncology Devices and Solutions Market, Growth-Share Matrix (by
Type), 2021-2031
Figure 38: Global Next-Generation Oncology Devices and Solutions Market (High-Intensity Focused
Ultrasound), $Million, 2020-2031
Figure 39: Global Next-Generation Oncology Devices and Solutions Market (Advanced Forms of Radiation
Therapy), $Million, 2020-2031
Figure 40: Global Next-Generation Oncology Devices and Solutions Market (Others), $Million, 2020-2031
Figure 41: Global Next-Generation Oncology Devices and Solutions Market, Devices (Diagnosis), $Million,
2020-2031
Figure 42: Global Next-Generation Oncology Devices and Solutions Market, Devices (Treatment and
Monitoring), $Million, 2020-2031
Figure 43: Global Next-Generation Oncology Devices and Solutions Market, Software (Diagnosis), $Million,
2020-2031
Figure 44: Global Next-Generation Oncology Devices and Solutions Market, Software (Treatment and
Monitoring), $Million, 2020-2031
16. 16
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
Figure 45: Global Next-Generation Oncology Devices and Solutions Market Share (by Region), 2021-2031
Figure 46: North America Next-Generation Oncology Devices and Solutions Market Incremental Opportunity
(by Country), $Million, 2021-2031
Figure 47: Prevalence of Different Cancer in North America, 2010, 2015, and 2019
Figure 48: Number of New Cases for All Cancers in North America, 2020-2040
Figure 49: North America Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 50: North America Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 51: North America Next-Generation Oncology Devices and Solutions Market (by End User), $Million,
2020-2031
Figure 52: North America Next-Generation Oncology Devices and Solutions Market (by Type), $Million,
2020-2031
Figure 53: North America Next-Generation Oncology Devices and Solutions Market, Devices (by
Technology), $Million, 2020-2031
Figure 54: North America Next-Generation Oncology Devices and Solutions Market, Devices (by
Application), $Million, 2020-2031
Figure 55: North America Next-Generation Oncology Devices and Solutions Market, Software (by
Application), $Million, 2020-2031
Figure 56: North America Next-Generation Oncology Devices and Solutions Market (by Country), $Million,
2021 and 2031
Figure 57: U.S. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 58: U.S. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million,
2020-2031
Figure 59: U.S. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 60: Canada Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 61: Canada Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 62: Canada Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 63: Europe Next-Generation Oncology Devices and Solutions Market Incremental Opportunity (by
Country), $Million, 2021-2031
Figure 64: Number of New Cases for All Cancers in Europe, 2020-2040
Figure 65: Europe Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 66: Europe Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
17. 17
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
Figure 67: Europe Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 68: Europe Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-2031
Figure 69: Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Technology),
$Million, 2020-2031
Figure 70: Europe Next-Generation Oncology Devices and Solutions Market, Devices (by Application),
$Million, 2020-2031
Figure 71: Europe Next-Generation Oncology Devices and Solutions Market, Software (by Application),
$Million, 2020-2031
Figure 72: Europe Next-Generation Oncology Devices and Solutions Market (by Country), $Million, 2021
and 2031
Figure 73: Germany Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 74: Germany Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 75: Germany Next-Generation Oncology Devices and Solutions Market (by End User), $Million,
2020-2031
Figure 76: U.K. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 77: U.K. Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million,
2020-2031
Figure 78: U.K. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 79: France Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 80: France Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 81: France Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 82: Italy Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 83: Italy Next-Generation Oncology Devices and Solutions Market (by Clinical Application), $Million,
2020-2031
Figure 84: Italy Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 85: Spain Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 86: Spain Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 87: Spain Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
18. 18
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
Figure 88: Rest-of-Europe Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 89: Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by Clinical
Application), $Million, 2020-2031
Figure 90: Rest-of-Europe Next-Generation Oncology Devices and Solutions Market (by End User),
$Million, 2020-2031
Figure 91: Asia-Pacific Next-Generation Oncology Devices and Solutions Market Incremental Opportunity
(by Country), $Million, 2021-2031
Figure 92: Prevalence of Different Cancer in Asia-Pacific, 2010, 2015, and 2019
Figure 93: Number of New Cases for All Cancers in Asia-Pacific, 2020-2040
Figure 94: Asia-Pacific Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 95: Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 96: Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User), $Million,
2020-2031
Figure 97: Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Type), $Million, 2020-
2031
Figure 98: Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Technology),
$Million, 2020-2031
Figure 99: Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Devices (by Application),
$Million, 2020-2031
Figure 100: Asia-Pacific Next-Generation Oncology Devices and Solutions Market, Software (by
Application), $Million, 2020-2031
Figure 101: Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Country), $Million,
2021 and 2031
Figure 102: Japan Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 103: Japan Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 104: Japan Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 105: China Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 106: China Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 107: China Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 108: Australia Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
19. 19
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
Figure 109: Australia Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 110: Australia Next-Generation Oncology Devices and Solutions Market (by End User), $Million,
2020-2031
Figure 111: India Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 112: India Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 113: India Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 114: South Korea Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 115: South Korea Next-Generation Oncology Devices and Solutions Market (by Clinical
Application), $Million, 2020-2031
Figure 116: South Korea Next-Generation Oncology Devices and Solutions Market (by End User), $Million,
2020-2031
Figure 117: Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market, $Million, 2020-
2031
Figure 118: Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by Clinical
Application), $Million, 2020-2031
Figure 119: Rest-of-Asia-Pacific Next-Generation Oncology Devices and Solutions Market (by End User),
$Million, 2020-2031
Figure 120: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Incremental
Opportunity (by Country), $Million, 2021-2031
Figure 121: Number of New Cases for All Cancers in Africa and Latin America, 2020-2040
Figure 122: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, $Million, 2020-
2031
Figure 123: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Clinical
Application), $Million, 2020-2031
Figure 124: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End User),
$Million, 2020-2031
Figure 125: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Type),
$Million, 2020-2031
Figure 126: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by
Technology), $Million, 2020-2031
Figure 127: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Devices (by
Application), $Million, 2020-2031
Figure 128: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, Software (by
Application), $Million, 2020-2031
20. 20
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
Figure 129: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by Country),
$Million, 2021 and 2031
Figure 130: K.S.A. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 131: K.S.A. Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 132: K.S.A. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 133: Brazil Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 134: Brazil Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 135: Brazil Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 136: U.A.E. Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 137: U.A.E. Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 138: U.A.E. Next-Generation Oncology Devices and Solutions Market (by End User), $Million, 2020-
2031
Figure 139: Mexico Next-Generation Oncology Devices and Solutions Market, $Million, 2020-2031
Figure 140: Mexico Next-Generation Oncology Devices and Solutions Market (by Clinical Application),
$Million, 2020-2031
Figure 141: Mexico Next-Generation Oncology Devices and Solutions Market (by End User), $Million,
2020-2031
Figure 142: Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market, $Million,
2020-2031
Figure 143: Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by
Clinical Application), $Million, 2020-2031
Figure 144: Rest-of-Rest-of-the-World Next-Generation Oncology Devices and Solutions Market (by End
User), $Million, 2020-2031
Figure 145: Share of Key Developments and Strategies, January 2018-April 2022
Figure 146: Regulatory and Legal Activities (by Company), January 2018-April 2022
Figure 147: Partnerships, Alliances, and Business Expansions (by Company), January 2018-April 2022
Figure 148: New Offerings (by Company), January 2018-April 2022
Figure 149: Mergers and Acquisitions (by Company), January 2018-April 2022
Figure 150: Funding Activities (by Company), January 2018-April 2022
Figure 151: Global Next-Generation Oncology Devices and Solutions Market, Company Revenue Share
Analysis, $Million, 2021
21. 21
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
List of Tables
Table 1: Global Next-Generation Oncology Devices and Solutions Market, Quarterly Key Developments
Analysis, January 2018-April 2022
Table 2: Global Next-Generation Oncology Devices and Solutions Market, Key Entry Barriers and
Possible Solutions
Table 3: Key Software Solutions in Oncology
Table 4: Key Technologies and Products in Oncology for Diagnosis and Treatment
Table 5: Key Players Offering HIFU Devices for Cancer
Table 6: Key Products Based on IGRT and IMRT Technology
Table 7: Key Players Offering Next-Generation Oncology Devices for Diagnosis
Table 8: Key Players Offering Next-Generation Oncology Devices for Treatment and Monitoring of Cancer
Table 9: Key Players Offering Next-Generation Oncology Software for Diagnosis
Table 10: Key Players Offering Next-Generation Oncology Software for Treatment and Monitoring
Table 11: North America Next-Generation Oncology Devices and Solutions Market Regulatory Framework
Table 12: U.S. Next-Generation Oncology Devices and Solutions Market, Key Players and Product Offering
Table 13: North America Next-Generation Oncology Devices and Solutions Market Dynamics Impact
Analysis
Table 14: Key Players in France Next-Generation Oncology Devices and Software Market
Table 15: Key Players in Rest-of-Europe Next-Generation Oncology Devices and Solutions Market
Table 16: Europe Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis
Table 17: Asia-Pacific Next-Generation Oncology Devices and Solutions Market Regulatory Framework
Table 18: Asia-Pacific Next-Generation Oncology Devices and Solutions Market Dynamics Impact Analysis
Table 19: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Regulatory
Framework
Table 20: Rest-of-the-World Next-Generation Oncology Devices and Solutions Market Dynamics Impact
Analysis
22. 22
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
BIS Research Offerings:
We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s
digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions
worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other
innovative solutions.
Know More Know More
Know More
Know More
23. 23
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth.
This document and its contents are confidential and may not be further distributed, published, or reproduced,
in whole or in part, by any medium or in any form for any purpose, without the written consent of BIS Research
Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through
incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to
generate any statistical or other information that is or will be provided to third parties; or voluntarily produce
Information in legal proceedings.
Market reports are based on expectations, estimates, and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to
market fluctuations and business, economic and competitive uncertainties and contingencies
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135
24. 24
All rights reserved at BIS Research Inc.
N
e
x
t
-
G
e
n
e
r
a
t
i
o
n
O
n
c
o
l
o
g
y
D
e
v
i
c
e
s
a
n
d
S
o
l
u
t
i
o
n
s
M
a
r
k
e
t
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com